Clinical efficacy of two different doses of rituximab as a treatment option in adult patients with chronic immune thrombocytopenia
Abstract Background Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with a high incidence of chronicity among adults. Rituximab is recommended as a treatment option for chronic ITP with the best long-term effect compared with other therapies. However, the optimal dose of rituximab r...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
SpringerOpen,
2024-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|